DEERFIELD, Ill.--(BUSINESS WIRE)--OVATION Pharmaceuticals, Inc. announced today that it has named Samuel Yonren, M.D. (MRCP) as Vice President, Patient Safety with responsibility for global drug safety for all OVATION products.
DEERFIELD, Ill.--(BUSINESS WIRE)--OVATION Pharmaceuticals, Inc. announced today that it has named Samuel Yonren, M.D. (MRCP) as Vice President, Patient Safety with responsibility for global drug safety for all OVATION products.
